Stock Information
Lyell Immunopharma Inc (LYEL)
Ticker Symbol: LYEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $407.39 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -12.9752
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -85.71%
Latest News
-
Lyell Immunopharma, Inc. (LYEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript
Sat, May 23, 2026 12:20 AM
-
Lyell Immunopharma, Inc. (LYEL) Presents at H.C. Wainwright 4th Annual BioConnect Investor Conference Transcript
Fri, May 22, 2026 7:10 PM
Key Financials
Financial data not available